Last 12 months
Inside the activity.
5 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 08, 2021 Filed Sep 10, 2021 21:42 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
Tax withholdingCommon Stock, No Par Value | 2,410 | $72.23 | $174,074.30 |
DisclosureSEC source: 0001415889-21-004349 · form4-09102021_020944.xml · nonDerivative · entry 2 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 3,859 F1 · ownership.nature: Represents securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 21:42 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $17.27 | $86,350.00 |
DisclosureSEC source: 0001415889-21-004349 · form4-09102021_020944.xml · nonDerivative · entry 1 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By spouse Disclosed balance after: 6,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Represents securities held by the spouse of the reporting person. The reporting person expressly disclaims beneficial ownership of the securities owned by his spouse. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 20:48 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 2,000 | $0.00 Strike: $44.80 | $0.00 |
DisclosureSEC source: 0001415889-21-004345 · form4-09102021_010949.xml · derivative · entry 6 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 2,000 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 03/02/2019. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 20:48 UTC |
Parra Raul Jr.CFO AND TREASURER
|
SaleCommon Stock, No Par Value | 2,000 | $72.01 | $144,020.00 |
DisclosureSEC source: 0001415889-21-004345 · form4-09102021_010949.xml · nonDerivative · entry 2 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.00 to $72.03, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 08, 2021 Filed Sep 10, 2021 20:48 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionCommon Stock, No Par Value | 2,000 | $44.80 | $89,600.00 |
DisclosureSEC source: 0001415889-21-004345 · form4-09102021_010949.xml · nonDerivative · entry 1 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:16 UTC |
Evans Stephen C.Director
|
GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003139 · form4-06212021_040623.xml · nonDerivative · entry 1 Evans Stephen C. · CIK 0001844301 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,914 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The shares vest on June 17, 2022, subject to continued service to the issuer through the vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:14 UTC |
ANDERSON A SCOTTDirector
|
GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003138 · form4-06212021_040637.xml · nonDerivative · entry 1 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,085 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022, 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021, and 39,983 shares of common stock. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:12 UTC |
Floyd DavidDirector
|
GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003137 · form4-06212021_040638.xml · nonDerivative · entry 1 Floyd David · CIK 0001564203 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022 and 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:11 UTC |
Hogan James T.Director
|
GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003136 · form4-06212021_040639.xml · nonDerivative · entry 1 Hogan James T. · CIK 0001816127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022 and 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:11 UTC |
Gunderson Thomas J.Director
|
GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003135 · form4-06212021_040655.xml · nonDerivative · entry 1 Gunderson Thomas James · CIK 0001708144 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022 and 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:10 UTC |
Carpenter Lonny J.Director
|
GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003134 · form4-06212021_040610.xml · nonDerivative · entry 1 Carpenter Lonny J · CIK 0001451534 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,472 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022, 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021, and 370 shares of common stock. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:09 UTC |
Ward Lynne N.Director
|
GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003133 · form4-06212021_040627.xml · nonDerivative · entry 1 Ward Lynne · CIK 0001786127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022 and 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:08 UTC |
Millner F. Ann Ed.D.Director
|
GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003132 · form4-06212021_040647.xml · nonDerivative · entry 1 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,026 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022, 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021, and 13,924 shares of common stock. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. Read SEC document |
| June 17, 2021 Filed Jun 21, 2021 23:08 UTC |
Anderson JillDirector
|
GrantCommon Stock, No Par Value | 2,914 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-003131 · form4-06212021_040609.xml · nonDerivative · entry 1 Anderson Jill · CIK 0001764314 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,102 F1 · balance_after: The reported transaction involved the reporting person's receipt of a grant of 2,914 restricted stock units under the Merit Medical System, Inc. 2018 Long-Term Incentive Plan. The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 of Table I includes the 2,914 newly awarded restricted stock units that vest on June 17, 2022 and 4,188 previously reported time-vesting restricted stock units that vest on June 22, 2021. Vesting of restricted stock units is subject to continued service to the issuer through the vesting date. The Form 4 filed on June 4, 2019 incorrectly stated that the reporting person held 6,400 shares of common stock, but the reporting person did not own any shares at that time. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 23:40 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $17.27 | $0.00 |
DisclosureSEC source: 0001415889-21-003038 · form4-06162021_040614.xml · derivative · entry 4 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing 02/13/2016. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 23:40 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
SaleCommon Stock, No Par Value | 11,887 | $61.82 | $734,854.34 |
DisclosureSEC source: 0001415889-21-003038 · form4-06162021_040614.xml · nonDerivative · entry 2 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,456 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.71 to $61.96, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 15, 2021 Filed Jun 16, 2021 23:40 UTC |
Frost RonaldCHIEF OPERATING OFFICER
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $17.27 | $345,400.00 |
DisclosureSEC source: 0001415889-21-003038 · form4-06162021_040614.xml · nonDerivative · entry 1 Frost Ronald · CIK 0001595939 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,000 | $0.00 Strike: $16.05 | $0.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · derivative · entry 11 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2023-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 01/28/2017. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 4,000 | $0.00 Strike: $28.20 | $0.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · derivative · entry 10 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 4,000 shares Expires 2024-04-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 04/14/2018. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
SaleCommon Stock, No Par Value | 5,000 | $63.76 | $318,800.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · nonDerivative · entry 6 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.75 to $63.87, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionCommon Stock, No Par Value | 4,000 | $28.20 | $112,800.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · nonDerivative · entry 5 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionCommon Stock, No Par Value | 1,000 | $16.05 | $16,050.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · nonDerivative · entry 4 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,000 | $0.00 Strike: $16.05 | $0.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · derivative · entry 9 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2023-01-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 01/28/2017. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,000 | $0.00 Strike: $17.27 | $0.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · derivative · entry 8 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2022-02-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 02/03/2016. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
SaleCommon Stock, No Par Value | 2,000 | $63.16 | $126,320.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · nonDerivative · entry 3 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,343 Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionCommon Stock, No Par Value | 1,000 | $17.27 | $17,270.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · nonDerivative · entry 2 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2021 Filed May 26, 2021 21:24 UTC |
Parra Raul Jr.CFO AND TREASURER
|
Exercise / conversionCommon Stock, No Par Value | 1,000 | $16.05 | $16,050.00 |
DisclosureSEC source: 0001415889-21-002686 · form4-05262021_020551.xml · nonDerivative · entry 1 Parra Raul Jr. · CIK 0001742555 · CFO AND TREASURER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2021 Filed May 24, 2021 19:30 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-21-002650 · form4-05242021_120531.xml · derivative · entry 4 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015. Read SEC document |
| May 21, 2021 Filed May 24, 2021 19:30 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
SaleCommon Stock, No Par Value | 15,000 | $62.03 | $930,450.00 |
DisclosureSEC source: 0001415889-21-002650 · form4-05242021_120531.xml · nonDerivative · entry 2 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,343 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.15, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 21, 2021 Filed May 24, 2021 19:30 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Exercise / conversionCommon Stock, No Par Value | 15,000 | $12.06 | $180,900.00 |
DisclosureSEC source: 0001415889-21-002650 · form4-05242021_120531.xml · nonDerivative · entry 1 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2021 Filed May 20, 2021 12:40 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001415889-21-002580 · form4-05202021_050527.xml · derivative · entry 7 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 15,000 shares Expires 2024-05-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/24/2018. Read SEC document |
| May 17, 2021 Filed May 20, 2021 12:40 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0001415889-21-002580 · form4-05202021_050527.xml · derivative · entry 6 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 15,000 shares Expires 2023-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017. Read SEC document |
| May 17, 2021 Filed May 20, 2021 12:40 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 15,000 | $0.00 Strike: $20.27 | $0.00 |
DisclosureSEC source: 0001415889-21-002580 · form4-05202021_050527.xml · derivative · entry 5 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,000 shares Expires 2022-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2016. Read SEC document |
| May 17, 2021 Filed May 20, 2021 12:40 UTC |
ANDERSON A SCOTTDirector
|
SaleCommon Stock, No Par Value | 23,779 | $59.19 | $1,407,479.01 |
DisclosureSEC source: 0001415889-21-002580 · form4-05202021_050527.xml · nonDerivative · entry 4 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,983 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.00 to $59.51, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 17, 2021 Filed May 20, 2021 12:40 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionCommon Stock, No Par Value | 15,000 | $20.27 | $304,050.00 |
DisclosureSEC source: 0001415889-21-002580 · form4-05202021_050527.xml · nonDerivative · entry 3 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2021 Filed May 20, 2021 12:40 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionCommon Stock, No Par Value | 15,000 | $34.40 | $516,000.00 |
DisclosureSEC source: 0001415889-21-002580 · form4-05202021_050527.xml · nonDerivative · entry 2 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 17, 2021 Filed May 20, 2021 12:40 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionCommon Stock, No Par Value | 15,000 | $18.80 | $282,000.00 |
DisclosureSEC source: 0001415889-21-002580 · form4-05202021_050527.xml · nonDerivative · entry 1 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 07, 2021 Filed May 10, 2021 20:48 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $19.72 | $0.00 |
DisclosureSEC source: 0001415889-21-002388 · form4-05102021_010547.xml · derivative · entry 4 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Become exercisable in equal annual installments of 20% commencing on 05/02/2017. Read SEC document |
| May 07, 2021 Filed May 10, 2021 20:48 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
SaleCommon Stock, No Par Value | 5,000 | $64.62 | $323,100.00 |
DisclosureSEC source: 0001415889-21-002388 · form4-05102021_010547.xml · nonDerivative · entry 2 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,039 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.51 to $65.10, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 07, 2021 Filed May 10, 2021 20:48 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $19.72 | $98,600.00 |
DisclosureSEC source: 0001415889-21-002388 · form4-05102021_010547.xml · nonDerivative · entry 1 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,039 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:21 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-21-002393 · form4-05102021_030509.xml · derivative · entry 3 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 5,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015. Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:21 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
SaleCommon Stock, No Par Value | 5,000 | $64.75 | $323,750.00 |
DisclosureSEC source: 0001415889-21-002393 · form4-05102021_030509.xml · nonDerivative · entry 2 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,343 Read SEC document |
| May 06, 2021 Filed May 10, 2021 22:21 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $12.06 | $60,300.00 |
DisclosureSEC source: 0001415889-21-002393 · form4-05102021_030509.xml · nonDerivative · entry 1 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 6, 2021 15:11 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $12.06 | $0.00 |
DisclosureSEC source: 0001415889-21-002309 · form4-05062021_080526.xml · derivative · entry 3 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires 2021-10-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015. Read SEC document |
| May 04, 2021 Filed May 6, 2021 15:11 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
SaleCommon Stock, No Par Value | 5,000 | $64.25 | $321,250.00 |
DisclosureSEC source: 0001415889-21-002309 · form4-05062021_080526.xml · nonDerivative · entry 2 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,343 Read SEC document |
| May 04, 2021 Filed May 6, 2021 15:11 UTC |
Wright JosephPRESIDENT, INTERNATIONAL
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $12.06 | $60,300.00 |
DisclosureSEC source: 0001415889-21-002309 · form4-05062021_080526.xml · nonDerivative · entry 1 Wright Joseph · CIK 0001643713 · PRESIDENT, INTERNATIONAL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,343 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 13, 2021 Filed May 10, 2021 20:48 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
GiftCommon Stock, No Par Value | 2,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-002388 · form4-05102021_010547.xml · nonDerivative · entry 3 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,696 Read SEC document |
| March 19, 2021 Filed Mar 24, 2021 01:38 UTC |
Lampropoulos Fred P.Director · PRESIDENT AND CEO
|
GrantNon-qualified stock options (right to buy) · Derivative | 58,083 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001415889-21-001634 · form4-03232021_060307.xml · derivative · entry 5 LAMPROPOULOS FRED P · CIK 0000901534 · Director · PRESIDENT AND CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,083 Underlying: Common Stock · 58,083 shares Expires 2028-03-19 F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 25% commencing 3/19/2022. Read SEC document |
| March 19, 2021 Filed Mar 24, 2021 01:35 UTC |
Lampropoulos Justin J.PRESIDENT, EMEA
|
GrantNon-qualified stock options (right to buy) · Derivative | 9,681 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001415889-21-001633 · form4-03232021_060338.xml · derivative · entry 2 Lampropoulos Justin J. · CIK 0001643609 · PRESIDENT, EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681 Underlying: Common Stock · 9,681 shares Expires 2028-03-19 F1 · derivative.exercise_date: Become exercisable in equal annual installments of 25% commencing on 03/19/2022. Read SEC document |
| March 19, 2021 Filed Mar 24, 2021 01:33 UTC |
Lloyd Brian G.CHIEF LEGAL OFFICER, SECRETARY
|
GrantNon-qualified stock options (right to buy) · Derivative | 9,681 | $0.00 Strike: $56.25 | $0.00 |
DisclosureSEC source: 0001415889-21-001632 · form4-03232021_060314.xml · derivative · entry 2 Lloyd Brian G. · CIK 0001671772 · CHIEF LEGAL OFFICER, SECRETARY 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,681 Underlying: Common Stock · 9,681 shares Expires 2028-03-19 F1 · derivative.exercise_date: Become exercisable in equal annual installments of 25% commencing on 03/19/2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.